Back
CytomX Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
CTMX
CytomX Therapeutics
Last Price:
$1.09
Seasonality Move:
-0.08%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.CytomX Therapeutics Stock Forecast
-
Is CytomX Therapeutics Stock Undervalued?The current CytomX Therapeutics [CTMX] share price is $1.09. The Score for CTMX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CTMX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will CytomX Therapeutics Stock Go Up Next Year?
Data Unavailable
CytomX Therapeutics Stock Rating
Data Unavailable
CytomX Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytomx.com
52-Week Data
52-Week High:
5.85
52-Week Low:
0.83
Prediction Charts
Market Cap:
85.3M
Price in USD:
1.09
Volume:
1.1M
Beta:
0.94
Technical Analysis
SMA50:
1.06
SMA100:
1.13
SMA200:
1.52
52-Wk Change:
-18.66%
Stock Predictions
-
Is CytomX Therapeutics stock public?Yes, CytomX Therapeutics is a publicly traded company.
-
What is the CytomX Therapeutics stock quote today?The CytomX Therapeutics stock price is 1.09 USD today.
-
How to buy CytomX Therapeutics stock online?You can buy CytomX Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 1.20 | 1.23 | 1.34 | 1.18 |
| Dec-4 | 1.22 | 1.29 | 1.42 | 1.21 |
| Dec-5 | 1.27 | 1.16 | 1.28 | 1.13 |
| Dec-6 | 1.19 | 1.18 | 1.25 | 1.17 |
| Dec-9 | 1.23 | 1.26 | 1.28 | 1.19 |
| Dec-10 | 1.24 | 1.21 | 1.25 | 1.17 |
| Dec-11 | 1.24 | 1.18 | 1.25 | 1.15 |
| Dec-12 | 1.17 | 1.12 | 1.17 | 1.08 |
| Dec-13 | 1.13 | 1.11 | 1.13 | 1.05 |
| Dec-16 | 1.12 | 1.15 | 1.16 | 1.09 |
| Dec-17 | 1.14 | 1.13 | 1.15 | 1.06 |
| Dec-18 | 1.12 | 1.06 | 1.12 | 1.00 |
| Dec-19 | 1.07 | 1.10 | 1.13 | 1.03 |
| Dec-20 | 1.06 | 1.09 | 1.10 | 1.03 |
CytomX Therapeutics Earnings
Data Unavailable
CytomX Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.44 per share.
* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.